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Background
Inclusion body formation is a common event during bac-
terial over-expression of recombinant genes. This phe-
nomenon represents a great matter of concern in
biotechnology, because it has restricted the spectrum of
proteins marketed in this field. In a previous work, we
have observed that recombinant enzymes produced in
bacteria are not completely inactivated when deposited as
inclusion bodies [1] and that aggregation as inclusion
bodies does not necessarily split protein population into
active and inactive fractions. Therefore, we decided to fur-
ther explore and fully characterize the behaviour of puri-
fied beta-galactosidase inclusion bodies in presence of
substrate, during a small-scale bioprocess.
Results
In this work we have analysed the state of the inclusion
bodies formed by an engineered E. coli beta-galactosidase
fused to the aggregation-prone foot-and-mouth disease
virus (FMDV) VP1 capsid protein (VP1LAC). Inclusion
bodies were resuspended in Z buffer and incubated at
37°C in agitation in presence of ONPG substrate (and in
its absence as internal control). Under these conditions,
the beta-galactosidase embedded in inclusion bodies effi-
ciently hydrolyses ONPG (Figure 1A), while no product
appears in absence of the substrate (Figure 1B). To quan-
tify the activity remaining in inclusion bodies and that
eventually present in the soluble fraction, during the incu-
bation of this aggregates with ONPG, samples were taken
at two points (t2 min and t30 min) and after centrifuga-
tion, the supernatant and the pellet were used for a second
enzymatic analysis with CPRG as substrate (Figure 2)
[1,2]. The amount of protein was also quantified in both
soluble and insoluble fractions at the times chosen (Table
1).
The results obtained, comparing the samples incubated
with and without ONPG (named control in Figure 2), sug-
gest that the presence of substrate in the suspension might
positively influence the solubilisation of the aggregated
protein.
Conclusion
We could conclude that, interestingly, when an enzyme
aggregated as inclusion bodies is incubated with its sub-
strate, part of this protein might be spontaneously solubi-
lised in a process that seems to be eventually favoured by
the presence of substrate. Moreover, this soluble protein
shows considerable enzymatic activity that is a major con-
tributor to the enzymatic process initiated by inclusion
bodies.
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A. Product formed by soluble fraction (A) and inclusion bodies (B) through CPRG hydrolysis as determined at 540 nmFigure 2
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Table 1: 
Protein (%) Inclusion bodies Soluble
t2 min t30 min t2 min t30 min
samples 100 28 <1 72
A. Product formed by inclusion bodies (quadruplicate) through ONPG hydrolysis as determined at 414 nmFigure 1
A. Product formed by inclusion bodies (quadruplicate) through ONPG hydrolysis as determined at 414 nm. B. Control (inclu-
sion bodies without ONPG).
time (min)
































Microbial Cell Factories 2006, 5(Suppl 1):P14Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




This work has been funded by BIO2004-00700 from MEC, Spain and 
2005SGR-00956 (AGAUR). Elena García-Fruitós is recipient of a doctoral 
fellowship from MEC, Spain.
References
1. García-Fruitós E, González-Montalbán N, Morell M, Vera A, Ferraz
RM, Arís A, Ventura S, Villaverde A: Aggregation as bacterial
inclusion bodies does not imply inactivation of enzymes and
fluorescent proteins.  Microb Cell Fact 2005, 4:27.
2. Ferraz RM, Aris A, Villaverde A: Profiling the allosteric response
of an engineered beta-galactosidase to its effector, anti-HIV
antibody.  Biochem Biophys Res Commun 2004, 314:854-860.Page 3 of 3
(page number not for citation purposes)
